In contrast, we find an enrichment of several markers of pulmonary fibrosis (CLU, COL1A1, COL1A2, and COL3A1) in SARS-CoV-2-low patients (these correspond to the later stages of infection), indicating that there are two distinct stages of infection.15 The gene discussed is COL3A1; the disease is pulmonary fibrosis.